These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20713566)

  • 1. The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series.
    Karst M; Halpern JH; Bernateck M; Passie T
    Cephalalgia; 2010 Sep; 30(9):1140-4. PubMed ID: 20713566
    [No Abstract]   [Full Text] [Related]  

  • 2. Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.
    Schindler EA; Gottschalk CH; Weil MJ; Shapiro RE; Wright DA; Sewell RA
    J Psychoactive Drugs; 2015; 47(5):372-81. PubMed ID: 26595349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is BOL-148 hallucinogenic?
    Tfelt-Hansen P
    Cephalalgia; 2011 Apr; 31(5):634; author reply 635-6. PubMed ID: 21163816
    [No Abstract]   [Full Text] [Related]  

  • 4. Problem child is no headache.
    Sewell RA; Gottschalk CH
    Headache; 2011 Feb; 51(2):306; author reply 306-7. PubMed ID: 21083559
    [No Abstract]   [Full Text] [Related]  

  • 5. Response of cluster headache to psilocybin and LSD.
    Sewell RA; Halpern JH; Pope HG
    Neurology; 2006 Jun; 66(12):1920-2. PubMed ID: 16801660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LSD-induced Hallucinogen Persisting Perception Disorder with depressive features treated with reboxetine: case report.
    Lerner AG; Shufman E; Kodesh A; Kretzmer G; Sigal M
    Isr J Psychiatry Relat Sci; 2002; 39(2):100-3. PubMed ID: 12227224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cluster busters.
    Frood A
    Nat Med; 2007 Jan; 13(1):10-1. PubMed ID: 17206116
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaire.
    Baggott MJ; Coyle JR; Erowid E; Erowid F; Robertson LC
    Drug Alcohol Depend; 2011 Mar; 114(1):61-7. PubMed ID: 21035275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSD use and flashbacks in alcoholic patients.
    Batzer W; Ditzler T; Brown C
    J Addict Dis; 1999; 18(2):57-63. PubMed ID: 10334376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-inflicted testicular amputation in first lysergic acid diethylamide use.
    Blacha C; Schmid MM; Gahr M; Freudenmann RW; Plener PL; Finter F; Connemann BJ; Schönfeldt-Lecuona C
    J Addict Med; 2013; 7(1):83-4. PubMed ID: 23222128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychophysiological effects of a large non-experimental dose of LSD-25.
    Reynolds HH; Peterson GK
    Psychol Rep; 1966 Aug; 19(1):287-90. PubMed ID: 5942100
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synesthesias in the context of hallucinogen-induced persistent perception disorder following the use of lsd].
    Neven A; Blom JD
    Tijdschr Psychiatr; 2014; 56(11):748-52. PubMed ID: 25401683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do hallucinogens cause residual neuropsychological toxicity?
    Halpern JH; Pope HG
    Drug Alcohol Depend; 1999 Feb; 53(3):247-56. PubMed ID: 10080051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache.
    GRAHAM JR
    N Engl J Med; 1960 Dec; 263():1273-7. PubMed ID: 13707731
    [No Abstract]   [Full Text] [Related]  

  • 15. Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach.
    Lerner AG; Gelkopf M; Skladman I; Oyffe I; Finkel B; Sigal M; Weizman A
    Isr J Psychiatry Relat Sci; 2002; 39(2):92-9. PubMed ID: 12227234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysergic acid diethylamide.
    O'Shea B; Fagan J
    Ir Med J; 2001; 94(7):217. PubMed ID: 11693215
    [No Abstract]   [Full Text] [Related]  

  • 17. [Psychoactive effects of 'legal high': About lysergic acid amide (LSA)].
    Ponté C; Lapeyre-Mestre M
    Therapie; 2017 Oct; 72(5):605-608. PubMed ID: 28457570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduced sympathetic nervous system activity during the cluster period of cluster-headache].
    Strittmatter M; Hamann GF; Blaes F; Grauer M; Fischer C; Hoffmann KH
    Schweiz Med Wochenschr; 1996 Jun; 126(24):1054-61. PubMed ID: 8701243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine treatment for hallucinogen persisting perception disorder.
    Lerner AG; Finkel B; Oyffe I; Merenzon I; Sigal M
    Am J Psychiatry; 1998 Oct; 155(10):1460. PubMed ID: 9766785
    [No Abstract]   [Full Text] [Related]  

  • 20. Variable adverse effects in subjects after ingestion of equal doses of Argyreia nervosa seeds.
    Kremer C; Paulke A; Wunder C; Toennes SW
    Forensic Sci Int; 2012 Jan; 214(1-3):e6-8. PubMed ID: 21803515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.